240 related articles for article (PubMed ID: 28214926)
21. Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy.
Khan AJ; Saraswat VA; Ranjan P; Parmar D; Negi TS; Mohindra S
J Med Virol; 2019 Apr; 91(4):659-667. PubMed ID: 30431653
[TBL] [Abstract][Full Text] [Related]
22. Assessment of IL-28: rs12979860 and rs8099917 Polymorphisms in a Cohort of Cuban Chronic HCV Genotype 1b Patients.
Palenzuela Gardón D; Guillen IA; Fernández JR; Camacho H; Estevez ZC; Dueñas S; Alvares-Lajonchere L; Amador Y; Martinez-Donato G; Han J; Zhang Z; Zhang X; Gao Y; Campaña JR; Novoa LI
J Biomol Tech; 2017 Jul; 28(2):80-86. PubMed ID: 28058039
[TBL] [Abstract][Full Text] [Related]
23. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
24. [The difference of IL-28B polymorphisms between hepatitis C patients with and without cryoglobulinemia].
Fan XH; Wu CH; Zheng YY; Wang LF; Huo N; Shao CP; Lu HY; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):429-33. PubMed ID: 24034843
[TBL] [Abstract][Full Text] [Related]
25. High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan.
Cheng CH; Lin CC; Chen HL; Lin IT; Wu CH; Lee YK; Wong MW; Bair MJ
Kaohsiung J Med Sci; 2017 Oct; 33(10):510-515. PubMed ID: 28962822
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.
Shaker OG; Sadik NA
J Gastroenterol Hepatol; 2012 Dec; 27(12):1842-9. PubMed ID: 23020144
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
Abdelwahab SF; Zakaria Z; Allam WR; Hamdy S; Mahmoud MA; Sobhy M; Rewisha E; Waked I
Arch Virol; 2015 Nov; 160(11):2833-7. PubMed ID: 26280523
[TBL] [Abstract][Full Text] [Related]
28. Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C.
Attallah AM; Omran D; Omran MM; Abdelrazek MA; Zayed R; Essawey RE; Saif S; Farid A; Hassany M; Yosry A; Omar A
Ann Hepatol; 2018 July - August ,; 17(4):569-576. PubMed ID: 29893697
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.
Huang CF; Yeh ML; Hsieh MH; Hsieh MY; Lin ZY; Chen SC; Wang LY; Huang JF; Juo SH; Lin YC; Dai CY; Chuang WL; Yu ML
J Gastroenterol Hepatol; 2013 Sep; 28(9):1515-20. PubMed ID: 23560893
[TBL] [Abstract][Full Text] [Related]
30. Factors that predict response of patients with hepatitis C virus infection to boceprevir.
Poordad F; Bronowicki JP; Gordon SC; Zeuzem S; Jacobson IM; Sulkowski MS; Poynard T; Morgan TR; Molony C; Pedicone LD; Sings HL; Burroughs MH; Sniukiene V; Boparai N; Goteti VS; Brass CA; Albrecht JK; Bacon BR;
Gastroenterology; 2012 Sep; 143(3):608-618.e5. PubMed ID: 22626609
[TBL] [Abstract][Full Text] [Related]
31. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
Duarte-Rojo A; Budhraja V; Veldt BJ; Goldstein DD; Watt KD; Heimbach JK; McHutchison JG; Tillman HL; Poterucha JJ; Charlton MR
Liver Transpl; 2013 Dec; 19(12):1311-7. PubMed ID: 24039107
[TBL] [Abstract][Full Text] [Related]
33. IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients.
Hsu CS; Hsu SJ; Liu WL; Chen CL; Liu CJ; Chen PJ; Chen DS; Kao JH
Antivir Ther; 2013; 18(4):599-606. PubMed ID: 23296193
[TBL] [Abstract][Full Text] [Related]
34. An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
Mangia A; Thompson AJ; Santoro R; Piazzolla V; Tillmann HL; Patel K; Shianna KV; Mottola L; Petruzzellis D; Bacca D; Carretta V; Minerva N; Goldstein DB; McHutchison JG
Gastroenterology; 2010 Sep; 139(3):821-7, 827.e1. PubMed ID: 20621700
[TBL] [Abstract][Full Text] [Related]
35. Distribution of IL-28B genotypes in patients with hepatitis C and healthy individuals in Jahrom city.
Mousavi Nasab SD; Baharlou R; Piroozmand A; Toghyani H; Shadmand E; Fazel H; Sadeghi K; Hashemi SM; Shokouh MR; Gheshlaghi A; Ahmadi NA; Ahmadi Vasmehjani A
Gastroenterol Hepatol Bed Bench; 2015; 8(4):278-87. PubMed ID: 26468348
[TBL] [Abstract][Full Text] [Related]
36. [Genetic polymorphisms of IL-28B are associated with sustained virologic response in patients with chronic hepatitis C].
Xie JQ; Guo XY; Cao H; Zhang XH; Xie DY; Gao ZL; Zhao ZX
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):892-5. PubMed ID: 23522248
[TBL] [Abstract][Full Text] [Related]
37. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-28B polymorphisms and interferon gamma inducible protein-10 serum levels in seronegative occult hepatitis C virus infection.
Bartolomé J; Castillo I; Quiroga JA; Carreño V
J Med Virol; 2016 Feb; 88(2):268-74. PubMed ID: 26147900
[TBL] [Abstract][Full Text] [Related]
39. Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.
Falleti E; Bitetto D; Fabris C; Cussigh A; Fornasiere E; Cmet S; Fumolo E; Bignulin S; Fontanini E; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Clin Immunol; 2011 Oct; 31(5):891-9. PubMed ID: 21647799
[TBL] [Abstract][Full Text] [Related]
40. Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.
Graziadei IW; Zoller HM; Schloegl A; Nachbaur K; Pfeiffer KP; Mark W; Mikuz G; Pratschke J; Margreiter R; Vogel W
Liver Transpl; 2012 Jun; 18(6):671-9. PubMed ID: 22298465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
